These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 20128985)
21. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
22. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
23. Vitamin D effects in atopic dermatitis. Samochocki Z; Bogaczewicz J; Jeziorkowska R; Sysa-Jędrzejowska A; Glińska O; Karczmarewicz E; McCauliffe DP; Woźniacka A J Am Acad Dermatol; 2013 Aug; 69(2):238-44. PubMed ID: 23643343 [TBL] [Abstract][Full Text] [Related]
24. The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool. Carel K; Bratton DL; Miyazawa N; Gyorkos E; Kelsay K; Bender B; Strand M; Atkins D; Gelfand EW; Klinnert MD Ann Allergy Asthma Immunol; 2008 Nov; 101(5):500-7. PubMed ID: 19055204 [TBL] [Abstract][Full Text] [Related]
25. Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life. Coutanceau C; Stalder JF Dermatology; 2014; 229(3):248-55. PubMed ID: 25196258 [TBL] [Abstract][Full Text] [Related]
26. Progressive muscle relaxation therapy for atopic dermatitis: objective assessment of efficacy. Bae BG; Oh SH; Park CO; Noh S; Noh JY; Kim KR; Lee KH Acta Derm Venereol; 2012 Jan; 92(1):57-61. PubMed ID: 21879233 [TBL] [Abstract][Full Text] [Related]
28. Resting energy expenditure, oxygen consumption and carbon dioxide production during sleep in children with atopic dermatitis. Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Yin JA; Fok TF J Dermatolog Treat; 2005 Feb; 16(1):22-5. PubMed ID: 15897163 [TBL] [Abstract][Full Text] [Related]
29. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity. Ezzat MH; Sallam MA; Shaheen KY Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860 [TBL] [Abstract][Full Text] [Related]
30. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. Yano C; Saeki H; Ishiji T; Ishiuji Y; Sato J; Tofuku Y; Nakagawa H J Dermatol; 2013 Sep; 40(9):736-9. PubMed ID: 23834561 [TBL] [Abstract][Full Text] [Related]
31. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363 [TBL] [Abstract][Full Text] [Related]
32. An assessment of anxiety and dermatology life quality in patients with atopic dermatitis. Linnet J; Jemec GB Br J Dermatol; 1999 Feb; 140(2):268-72. PubMed ID: 10233221 [TBL] [Abstract][Full Text] [Related]
33. Plasma endothelin-1 levels during exacerbation of atopic dermatitis. Tsybikov NN; Petrisheva IV; Kuznik BI; Magen E Allergy Asthma Proc; 2015; 36(4):320-4. PubMed ID: 26108089 [TBL] [Abstract][Full Text] [Related]
34. Stress evaluation in adult patients with atopic dermatitis using salivary cortisol. Mizawa M; Yamaguchi M; Ueda C; Makino T; Shimizu T Biomed Res Int; 2013; 2013():138027. PubMed ID: 23971022 [TBL] [Abstract][Full Text] [Related]
35. Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores. Angelova-Fischer I; Hipler UC; Bauer A; Fluhr JW; Tsankov N; Fischer TW; Elsner P Br J Dermatol; 2006 Jun; 154(6):1112-7. PubMed ID: 16704642 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of inpatient treatment for atopic dermatitis evaluated by changes in serum cortisol levels. Fukuda H; Suzuki T; Saotome A; Sode E; Mukai H J Dermatol; 2013 Jan; 40(1):43-7. PubMed ID: 23039140 [TBL] [Abstract][Full Text] [Related]
37. The significance of structured parental educational intervention on childhood atopic dermatitis: a randomized controlled trial. Pustišek N; Šitum M; Vurnek Živković M; Ljubojević Hadžavdić S; Vurnek M; Niseteo T J Eur Acad Dermatol Venereol; 2016 May; 30(5):806-12. PubMed ID: 26616256 [TBL] [Abstract][Full Text] [Related]
38. Assessment of serum 25-hydroxyvitamin d levels in children with atopic dermatitis: correlation with SCORAD index. El Taieb MA; Fayed HM; Aly SS; Ibrahim AK Dermatitis; 2013; 24(6):296-301. PubMed ID: 24201460 [TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of nocturnal scratching in childhood atopic dermatitis: the role of brain-derived neurotrophic factor and substance P. Hon KL; Lam MC; Wong KY; Leung TF; Ng PC Br J Dermatol; 2007 Nov; 157(5):922-5. PubMed ID: 17725670 [TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children. Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]